Skip to content

Clinical trials

Phase 2 Peanut Hypersensitivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peanut Hypersensitivity Phase: Phase 2 Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20093
20121
20134
20143
20151
20171
20181
20192
20201
20211
20221
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of North Carolina, Chapel Hill6
National Institute of Allergy and Infectious Diseases (NIAID)3
Aimmune Therapeutics, Inc.2
DBV Technologies2
Johns Hopkins University2
Regeneron Pharmaceuticals2
Stanford University2
AnaptysBio, Inc.1
Aravax Pty Ltd1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peanut Hypersensitivity25
Food Hypersensitivity14
Hypersensitivity7
Hypersensitivity, Immediate3
Anaphylaxis1
Egg Hypersensitivity1
Immune System Diseases1
Milk Hypersensitivity1
Nut Hypersensitivity1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.